The excitement for Ctix will return with the start of the kevetrin trial. It is what most of us long time investors bought into Ctix years ago. It also seems obvious to me that a pharma company wants this short 10 patient trial. I have not heard anyone else say this but I believe kevetrin will be the first partnered drug for Ctix. These cancer trials and method of actions are very difficult and time consuming. Big pharma has the people and resources to run these trials, which Ctix does not. If all big pharma wants to see is p53, p21 confirmation, the deal could be inked 3 months after start. I feel the excitement returning inside me, I just never had passion for the other drugs even though they may become very lucrative. Keep up the good work guys!!
P.s. Hoping for judges decision and sanctions on Friday